.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Baxter
Moodys
Federal Trade Commission
Covington
Harvard Business School
Accenture
Julphar
Dow
Cerilliant

Generated: November 24, 2017

DrugPatentWatch Database Preview

Details for Patent: 7,413,747

« Back to Dashboard

Which drugs does patent 7,413,747 protect, and when does it expire?


Patent 7,413,747 protects NEUPRO and is included in one NDA. There has been one Paragraph IV challenge on Neupro.

This patent has forty patent family members in thirty countries.

Summary for Patent: 7,413,747

Title:Transdermal therapeutic system for treating Parkinsonism
Abstract:A transdermal therapeutic system (TTS) comprises a silicone-based polymer adhesive system having distributed therein (-)-5,6,7,8-tetrahydro-6-[propyl-[2-(2-thienyl)ethyl]amino]-1-naphthaleno- l free base in an amount of about 5% to 40% by weight. The adhesive system comprises a silicone adhesive and an additive having increased solubility for the active substance, in an amount effective to increase dissolving capacity of the matrix for the active substance.
Inventor(s): Mueller; Walter (Neuwied, DE), Peck; James V. (Richmond, VA)
Assignee: LTS Lohmann Therapie-Systeme AG (Andernach, DE) Schwarz Pharma Limited (Shannon, IE)
Application Number:11/931,666
Patent Claim Types:
see list of patent claims
Compound; Delivery;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Ucb Inc
NEUPRO
rotigotine
FILM, EXTENDED RELEASE;TRANSDERMAL021829-004Apr 2, 2012RXYesNo► Subscribe► SubscribeY
Ucb Inc
NEUPRO
rotigotine
FILM, EXTENDED RELEASE;TRANSDERMAL021829-001May 9, 2007RXYesYes► Subscribe► SubscribeY
Ucb Inc
NEUPRO
rotigotine
FILM, EXTENDED RELEASE;TRANSDERMAL021829-005Apr 2, 2012RXYesNo► Subscribe► SubscribeY
Ucb Inc
NEUPRO
rotigotine
FILM, EXTENDED RELEASE;TRANSDERMAL021829-002May 9, 2007RXYesNo► Subscribe► SubscribeY
Ucb Inc
NEUPRO
rotigotine
FILM, EXTENDED RELEASE;TRANSDERMAL021829-003May 9, 2007RXYesNo► Subscribe► SubscribeY
Ucb Inc
NEUPRO
rotigotine
FILM, EXTENDED RELEASE;TRANSDERMAL021829-006Apr 2, 2012RXYesNo► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 7,413,747

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany198 14 084Mar 30, 1998

Non-Orange Book Patents for Patent: 7,413,747

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,884,434 Transdermal therapeutic system which contains a d2 agonist and which is provided for treating parkinsonism, and a method for the production thereof► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 7,413,747

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Norway20080489► Subscribe
Norway2008014► Subscribe
Norway325766► Subscribe
Norway20004915► Subscribe
Netherlands300236► Subscribe
Malaysia119660► Subscribe
Luxembourg91269► Subscribe
South Korea100432276► Subscribe
Japan3984785► Subscribe
Japan2002509878► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Chubb
Citi
Medtronic
McKinsey
Julphar
Argus Health
Colorcon
QuintilesIMS
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot